At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes

Arecor Therapeutics plc AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES AT278 demonstrates...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Austria ,David Daley ,Susan Lowther ,Chris Gardner ,Claes Spang ,Nigel Barnes ,David Wilson ,Thomas Pieber ,Sarah Howell ,Freddy Crossley ,Satheesh Nadarajah ,Lindsey Neville ,Wg Partners ,Panmure Gordon United Kingdom Limited ,Division Of Endocrinology ,Department Of Internal Medicine ,Globenewswire Inc ,Arecor Therapeutics ,Chief Executive Officer ,Principal Investigator ,Internal Medicine ,Abuse Regulation ,Aspart Formulation ,Crossover Study ,People With Type ,Partners Diabetes Bluebook ,Chief Executive ,Chief Financial ,Corporate Finance ,Corporate Broking ,Financial Advisor ,